These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 18304529
1. The effects of beta(3)-adrenoceptor agonist CL-316,243 on adiponectin, adiponectin receptors and tumor necrosis factor-alpha expressions in adipose tissues of obese diabetic KKAy mice. Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y. Eur J Pharmacol; 2008 Apr 14; 584(1):202-6. PubMed ID: 18304529 [Abstract] [Full Text] [Related]
2. beta-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-alpha expression in adipocytes. Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y. Eur J Pharmacol; 2007 Aug 13; 569(1-2):155-62. PubMed ID: 17574233 [Abstract] [Full Text] [Related]
3. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet. Kang JH, Goto T, Han IS, Kawada T, Kim YM, Yu R. Obesity (Silver Spring); 2010 Apr 13; 18(4):780-7. PubMed ID: 19798065 [Abstract] [Full Text] [Related]
4. Adiponectin receptor 2 expression in liver and insulin resistance in db/db mice given a beta3-adrenoceptor agonist. Oana F, Takeda H, Matsuzawa A, Akahane S, Isaji M, Akahane M. Eur J Pharmacol; 2005 Jul 25; 518(1):71-6. PubMed ID: 15979609 [Abstract] [Full Text] [Related]
5. The ameliorating effect of rosiglitazone on experimental nonalcoholic steatohepatitis is associated with regulating adiponectin receptor expression in rats. Liu S, Wu HJ, Zhang ZQ, Chen Q, Liu B, Wu JP, Zhu L. Eur J Pharmacol; 2011 Jan 10; 650(1):384-9. PubMed ID: 20965162 [Abstract] [Full Text] [Related]
6. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice. Liu LF, Purushotham A, Wendel AA, Belury MA. Am J Physiol Gastrointest Liver Physiol; 2007 Jun 10; 292(6):G1671-82. PubMed ID: 17322064 [Abstract] [Full Text] [Related]
7. Anti-obesity and anti-diabetic effects of CL316,243, a highly specific beta 3-adrenoceptor agonist, in Otsuka Long-Evans Tokushima Fatty rats: induction of uncoupling protein and activation of glucose transporter 4 in white fat. Umekawa T, Yoshida T, Sakane N, Saito M, Kumamoto K, Kondo M. Eur J Endocrinol; 1997 Apr 10; 136(4):429-37. PubMed ID: 9150705 [Abstract] [Full Text] [Related]
10. The effect of exercise training on adiponectin receptor expression in KKAy obese/diabetic mice. Huang H, Iida KT, Sone H, Yokoo T, Yamada N, Ajisaka R. J Endocrinol; 2006 Jun 10; 189(3):643-53. PubMed ID: 16731794 [Abstract] [Full Text] [Related]
13. Rosiglitazone Elicits an Adiponectin-Mediated Insulin-Sensitizing Action at the Adipose Tissue-Liver Axis in Otsuka Long-Evans Tokushima Fatty Rats. Li J, Xue YM, Zhu B, Pan YH, Zhang Y, Wang C, Li Y. J Diabetes Res; 2018 Jun 10; 2018():4627842. PubMed ID: 30225267 [Abstract] [Full Text] [Related]
14. Roux-en-Y gastric bypass alters tumor necrosis factor-α but not adiponectin signaling in immediate postoperative period in obese rats. Rideout DA, Peng Y, Rakita SS, Desai K, Gower WR, You M, Murr MM. Surg Obes Relat Dis; 2010 Jun 10; 6(6):676-80. PubMed ID: 20702148 [Abstract] [Full Text] [Related]
15. Effect of a beta-3 agonist on food intake in two strains of rats that differ in susceptibility to obesity. White CL, Ishihara Y, Dotson TL, Hughes DA, Bray GA, York DA. Physiol Behav; 2004 Sep 15; 82(2-3):489-96. PubMed ID: 15276814 [Abstract] [Full Text] [Related]
17. Beneficial direct adipotropic actions of pitavastatin in vitro and their manifestations in obese mice. Ishihara Y, Ohmori K, Mizukawa M, Hasan AU, Noma T, Kohno M. Atherosclerosis; 2010 Sep 15; 212(1):131-8. PubMed ID: 20466374 [Abstract] [Full Text] [Related]
19. Anti diabetic effect of CL 316,243 (a β3-adrenergic agonist) by down regulation of tumour necrosis factor (TNF-α) expression. Ghorbani M, Shafiee Ardestani M, Gigloo SH, Cohan RA, Inanlou DN, Ghorbani P. PLoS One; 2012 Sep 15; 7(10):e45874. PubMed ID: 23056223 [Abstract] [Full Text] [Related]